News
Senseonics Holdings
SENS · NYSE American
$8.21+$0.195 (+2.43%)TodayMarket closed ·
Prev close $8.02
Latest news
- News
Senseonics Partners With Beta Bionics To Integrate Its Eversense 365 CGM With Beta Bionics’ iLet Bionic Pancreas Automated Insulin Delivery System
- Press releaseGlobe Newswire
Senseonics Announces Strategic Partnership with Beta Bionics to Integrate Eversense® 365 with the iLet® Bionic Pancreas
- NewsAvi Kapoor
Coty Posts Mixed Q4 Results, Joins Wolfspeed, ATRenew And Other Big Stocks Moving Lower In Thursday’s Pre-Market Session
- NewsAvi Kapoor
Jim Cramer Says Buy Carpenter Technology, Calls This IT Services Stock a 'Value Trap'
- News
12 Health Care Stocks Moving In Friday's Intraday Session
- Press releaseGlobe Newswire
Senseonics Holdings, Inc. Reports Second Quarter 2026 Financial Results
- Press releaseGlobe Newswire
Senseonics Holdings, Inc. Schedules Second Quarter 2026 Earnings Release and Conference Call for August 6, 2026 at 4:30 P.M. Eastern Time
- Press releaseGlobe Newswire
Real-World Evidence of Eversense 365 Presented at ADA Demonstrating Strong Performance and Patient Impact in Both Open and Closed Loop Systems
- Press releaseGlobe Newswire
Senseonics Holdings, Inc. Reports First Quarter 2026 Financial Results
- Press releaseGlobe Newswire
Senseonics Enters Into Amended Loan Agreement with Hercules to Increase Borrowing Capacity to $140 Million
- NewsHenry Khederian
Senseonics Shares Sink Friday: What's Driving The Move?
- Press releaseGlobe Newswire
Senseonics Holdings, Inc. Schedules First Quarter 2026 Earnings Release and Conference Call for May 7, 2026 at 4:30 P.M. Eastern Time
- News
12 Health Care Stocks Moving In Friday's Pre-Market Session
- NewsAvi Kapoor
Why Twilio Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket
- News
12 Health Care Stocks Moving In Thursday's After-Market Session
- Press releasePRNewswire
The Quiet Rule Change Tilting $10B Toward Medtech's Most Validated Platforms
- Press releaseGlobe Newswire
Senseonics Announces European Launch of Eversense® 365, The World's First and Only One Year CGM System
- Press releasePRNewswire
MedTech's Edge: How AI and Remote Diagnostics Drive Scalable Value
- News
Senseonics Holdings: Q4 Earnings Insights
- Press releaseGlobe Newswire
Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results
- Press releaseBusiness Wire
Vistagen Appoints Nick Tressler as Chief Financial Officer
- News
Benzinga Bulls And Bears: Applied Digital, NVIDIA, Senseonics — And Markets Fall On Fresh Tariff Fears
- Press releaseBusiness Wire
Ascensia Diabetes Care Signs MOU to Transfer Eversense® CGM Distribution to Strategic Partner Senseonics
- News
Forecasting The Future: 4 Analyst Projections For Senseonics Holdings
- News
Earnings Scheduled For May 8, 2025
- NewsAvi Kapoor
Sangamo Therapeutics, Dave And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
- Press releasePRNewswire
Mercy Places First Commercial Eversense 365: The World's First and Only 365-Day Continuous Glucose Monitor
- Press releaseBusiness Wire
Eversense 365 Launches in the US: One Year. One CGM.
- Press releaseBusiness Wire
Eversense 365 Receives FDA Clearance: The World's First One Year CGM
- Press releaseBusiness Wire
Senseonics Holdings, Inc. Reports Second Quarter 2024 Financial Results
- Press releaseBusiness Wire
Senseonics Holdings, Inc. Schedules Second Quarter 2024 Earnings Release and Conference Call for August 8, 2024 at 4:30 P.M. Eastern Time
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.